BioHarvest Sciences Retained Earnings (Accumulated Deficit) 2020-2024 | BHST
BioHarvest Sciences retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
BioHarvest Sciences Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$-84 |
| 2022 |
$-71 |
| 2021 |
$-60 |
| 2020 |
$-50 |
| 2019 |
$-43 |
| 2019 |
$-5 |
| 2018 |
$-5 |
BioHarvest Sciences Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-06-30 |
$-91 |
| 2024-03-31 |
$-90 |
| 2023-12-31 |
$-84 |
| 2023-09-30 |
$-76 |
| 2023-06-30 |
$-75 |
| 2023-03-31 |
$-72 |
| 2022-12-31 |
$-71 |
| 2022-09-30 |
$-68 |
| 2022-06-30 |
$-64 |
| 2022-03-31 |
$-62 |
| 2021-12-31 |
$-60 |
| 2021-09-30 |
$-58 |
| 2021-06-30 |
$-55 |
| 2021-03-31 |
$-57 |
| 2020-12-31 |
$-50 |
| 2020-09-30 |
$-47 |
| 2020-06-30 |
$-45 |
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
$-5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
